Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Jonathan E Freeman is Director at Phio Pharmaceuticals. OQRO lists 1 transaction filed with the SEC under this name, the latest on Feb 6, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Jonathan E Freeman reported holding 32,655 shares of Phio Pharmaceuticals (PHIO), worth about $25K at the last close of $1 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Phio Pharmaceuticals PHIO | 32,655 | 33K direct | $1 | $25K | Feb 5, 2026 |
Is this Jonathan E Freeman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Feb 5, 202617Kdisclosed Feb 6
DetailsOfficial recordOn the latest SEC Form 4, dated Feb 5, 2026, Jonathan E Freeman reported holding 32,655 shares of Phio Pharmaceuticals (PHIO). At the last close of $1 on Nov 13, 2026, that is about $25K. This is the stake disclosed in filings, not a net worth.